iShares Neuroscience and Healthcare ETF (IBRN) Holdings $21.12 -0.68 (-3.12%) As of 03:26 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Holdings Stock AnalysisChartHoldingsOwnershipRatingsBuy This Stock Top 61 IBRN HoldingsRankCompanyCurrent PriceWeightShares Held1ITCIIntra-Cellular Therapies$131.877.00%1,8922PTCTPTC Therapeutics$46.76-3.3%5.30%3,3303ALKSAlkermes$31.65-3.1%4.85%5,0854CPRXCatalyst Pharmaceuticals$24.10-1.5%4.73%7,2645ACADACADIA Pharmaceuticals$16.12-3.0%4.47%9,2576SK Biopharmaceuticals Co., Ltd.N/A4.46%2,2307ARGXargenx$589.03+0.9%4.43%2578BIIBBiogen$130.65-0.5%4.03%1,0149SUPNSupernus Pharmaceuticals$32.50-1.0%3.91%4,30410NBIXNeurocrine Biosciences$102.86-5.0%3.86%1,248 Get the Latest News and Ratings for IBRN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for iShares Neuroscience and Healthcare ETF and its competitors with MarketBeat's FREE daily newsletter. 11H. LUNDBECK CLASS BN/A3.83%23,45212IARTIntegra LifeSciences$20.08-7.8%3.70%5,79213XENEXenon Pharmaceuticals$30.70-2.4%3.67%3,74414SRRKScholar Rock$30.69-5.7%3.47%3,67015EWTXEdgewise Therapeutics$13.51-12.9%3.29%4,90816BHVNBiohaven$20.52-13.3%2.83%3,57117SRPTSarepta Therapeutics$58.62-6.2%2.58%1,24818Neuren Pharmaceuticals LimitedN/A2.20%9,84319AVXLAnavex Life Sciences$8.29-3.1%2.01%7,18520BioArctic AB (publ)N/A1.99%3,41021AVDLAvadel Pharmaceuticals$7.20-3.6%1.88%7,71722DYNDyne Therapeutics$9.43-4.9%1.87%5,42223AXGNAxoGen$17.01-3.8%1.84%3,63124PRAXPraxis Precision Medicines$33.33-10.2%1.60%1,50825PRTAProthena$11.33-6.6%1.42%3,92026CAPRCapricor Therapeutics$9.28-4.8%1.41%3,49727SanBio Company LimitedN/A1.06%4,30028ZVRAZevra Therapeutics$7.44-2.9%1.05%4,64529DNTHDianthus Therapeutics$16.94-5.2%0.96%1,67630MicroPort NeuroScientific CorporationN/A0.86%18,00031CLPTClearPoint Neuro$12.13-7.3%0.80%2,09232MedinCell S.A.N/A0.71%1,57233VNDAVanda Pharmaceuticals$4.38-3.0%0.67%4,83234TSHATaysha Gene Therapies$1.27-4.2%0.64%13,44335NGNENeurogene$9.70-7.3%0.61%1,41536TRDAEntrada Therapeutics$7.97-9.4%0.56%1,90037ANNXAnnexon$1.83-6.9%0.55%7,81738ABEOAbeona Therapeutics$4.96+5.9%0.50%3,44339NVRONevro$5.85+0.1%0.50%3,09440RAPPRapport Therapeutics$8.50-14.7%0.43%1,529Trump… a socialist? (Ad)Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma41VYGRVoyager Therapeutics$3.10-9.0%0.43%3,95342SGMOSangamo Therapeutics$0.62-4.9%0.41%17,42243AMLXAmylyx Pharmaceuticals$3.51-7.3%0.40%3,78544SLDBSolid Biosciences$3.40-7.8%0.38%2,84745Idorsia LtdN/A0.36%10,58646SAVACassava Sciences$1.27-9.0%0.28%3,65747CTNMContineum Therapeutics$6.19-8.7%0.25%1,23048ALECAlector$1.10-7.2%0.24%6,60349LRMRLarimar Therapeutics$1.98-10.2%0.23%3,23950CLYMClimb Bio$1.15-5.0%0.16%4,50651ANROAlto Neuroscience$1.86-9.5%0.15%1,92252USDProShares Ultra Semiconductors$34.33-17.1%0.06%2,11053CHF CASHN/A0.03%89854KRW CASHN/A0.03%1,749,83555SEK CASHN/A0.03%11,01856HKDAMTD Digital$2.05-6.4%0.02%6,25357AUDAudacy0.02%1,09858DKK CASHN/A0.02%4,03359EUR CASHN/A0.01%38660JPY CASHN/A0.01%32,31061FUTURES USD MARGIN BALANCEN/A0.00%1 Geographic ExposureUnited States68.0%Ireland6.9%Canada4.6%Korea, Republic of4.0%Virgin Islands, British3.5%Denmark3.0%Sweden2.9%New Zealand1.8%Japan1.3%Switzerland0.8%France0.8%Cayman Islands0.7%Currency ExposureUSD84.6%KRW4.0%DKK3.1%SEK2.9%AUD1.9%JPY1.3%CHF0.8%EUR0.8%HKD0.7%Sector ExposureHealth Care66.5%Energy0.7%Industry ExposureBiotechnology59.7%Health Care Equipment & Supplies4.9%Pharmaceuticals1.8%Renewable Energy0.7%SubIndustry ExposureBiotechnology55.0%Health Care Equipment3.2%Pharmaceuticals2.0%Health Care Supplies1.7%Renewable Energy Equipment0.7%Coupon Exposure0-2100.0% Related Companies and Tools Related Companies NVIR Holdings SOLR Holdings EMTY Holdings KBUF Holdings THNR Holdings ARVR Holdings GLIF Holdings IVEG Holdings IRHG Holdings NZUS Holdings This page (NYSEARCA:IBRN) was last updated on 4/3/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredNew “Trump” currency proposed in DCAfter a massive run-up – tech stocks are crashing. And as you’d suspect, the rich and powerful got out firs...Paradigm Press | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Neuroscience and Healthcare ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Neuroscience and Healthcare ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IBRN Stock Free IBRN Stock Alerts